Received: from PAWPR02MB10090.eurprd02.prod.outlook.com (2603:10a6:102:358::7) by VI1PR02MB5024.eurprd02.prod.outlook.com with HTTPS; Wed, 20 May 2026 10:40:09 +0000 Received: from GV1PR02MB8353.eurprd02.prod.outlook.com (2603:10a6:150:54::21) by PAWPR02MB10090.eurprd02.prod.outlook.com (2603:10a6:102:358::7) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.48.14; Wed, 20 May 2026 10:40:07 +0000 Received: from GV1PR02MB8353.eurprd02.prod.outlook.com ([fe80::bac:5de1:56c4:91ac]) by GV1PR02MB8353.eurprd02.prod.outlook.com ([fe80::bac:5de1:56c4:91ac%3]) with mapi id 15.21.0048.013; Wed, 20 May 2026 10:40:06 +0000 From: "Kristi Sarap - RA" To: Subject: Estonian State Agency of Medicines answer Date: Wed, 20 May 2026 13:40:06 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0154_01DCEDE1.9B9BB650" X-Mailer: Microsoft Outlook 16.0 Authentication-Results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 20 May 2026 10:40:07.3669 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: f6aef9ad-ab7e-4d06-f978-08deb65c28b2 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GV1PR02MB8353:EE_|PAWPR02MB10090:EE_|VI1PR02MB5024:EE_ X-MS-Exchange-Organization-AuthSource: GV1PR02MB8353.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: f6aef9ad-ab7e-4d06-f978-08deb65c28b2 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|39142699007|31052699007|366016|55112099003|13003099007|18002099003|56012099003|8096899003|11063799006|41050700001; X-Forefront-Antispam-Report: CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GV1PR02MB8353.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(39142699007)(31052699007)(366016)(55112099003)(13003099007)(18002099003)(56012099003)(8096899003)(11063799006)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 20 May 2026 10:40:06.8634 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: f6aef9ad-ab7e-4d06-f978-08deb65c28b2 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GV1PR02MB8353.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAWPR02MB10090 X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.9825096 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0048.002 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 Thread-Index: AQLq7Vab/AzOVETDObC/J0TJxRvs6w== X-MS-Has-Attach: X-MS-TNEF-Correlator: X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-ExternalInOutlookResult: NotEnabled Content-Language: et x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 x-ms-exchange-organization-originalserveripaddress: 2603:10a6:150:54::21 acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-05-20T10:40:06.427Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; X-OlkEid: 000000004C30E2D3CD34B4428531CBEB8A7CAB89070034AD76187591974DBF6C4F76951C873A0100020000000000B04CDEF8D3227A448511457FBBCE9C8700000000097C0000F5B4E5700E2E1540ADB8238311B356F9 X-MS-Exchange-Organization-ModifySensitivityLabel: 00000000-0000-0000-0000-000000000000;defa4170-0d19-0005-0004-bc88714345d2 x-codetwo-clientsignature-inserted: true X-MS-Exchange-CrossTenant-MailboxType: HOSTED X-MS-Exchange-CrossTenant-UserPrincipalName: CgPJNeZaXAhfjgC0x7vfHX2pzvJkcAJDG0DyvHig2bqO5vm/XHgd9EIube8wHp76Cr/P4h8NcRatn/iygsP3Xoz04hwRHtCa3Lc579LtMcc= X-MS-Exchange-Organization-Recipient-P2-Type: Bcc This is a multipart message in MIME format. ------=_NextPart_000_0154_01DCEDE1.9B9BB650 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Thank you for your questions! The Estonian State Agency of Medicines currently does not have such information or datasets. We also discussed the topic of AI, patients, and social healthcare with colleagues from the Estonian Health Insurance Fund, however this topic has not yet been addressed in their work either. AI, patients, and social healthcare are certainly important and increasingly relevant topics in our field. We hope to collect this kind of data in cooperation with partners in the social sector in the near future. Best regards, Kristi Sarap Communication Adviser Estonian State Agency of Medicines Ravimiamet 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. ------=_NextPart_000_0154_01DCEDE1.9B9BB650 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable
Thank you for your questions!
The Estonian State Agency of Medicines currently does not have such = information or datasets. We also discussed the topic of AI, patients, = and social healthcare with colleagues from the Estonian Health Insurance = Fund, however this topic has not yet been addressed in their work either.
AI, patients, and social healthcare are certainly important and = increasingly relevant topics in our field.
We hope to collect this kind of data in cooperation with partners in the = social sector in the near future.

Best regards,

Kristi Sarap

Communication Adviser

Estonian State Agency of = Medicines




Ravimiamet

737 4140

www.ravimiamet.ee


Selles e-kirjas sisalduv teave (kaasa arvatud manused) on = m=C3=B5eldud ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada = vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja = selgelt v=C3=A4ljendatud loata edasi saata ega mis tahes viisil = kolmandatele isikutele avaldada. Juhul, kui Te olete saanud = k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, teavitage sellest koheselt = saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 

------=_NextPart_000_0154_01DCEDE1.9B9BB650--